Pharmafile Logo
Pharmafocus logo
Advanced Search

Biogaran acquires production foothold in Nigeria with Swipha acquisition

March 21, 2017
Manufacturing and Production, Sales and Marketing Biogaran, Swipharma

Biogaran, the French generic manufacturer that is a subsidiary of Servier, has acquired a foothold in Nigeria with a 95% …

News
thumbs_down

Array BioPharma in disarray over withdrawal of NDA

March 20, 2017
Manufacturing and Production, Sales and Marketing Array Biopharma

Array BioPharma has announced that it has pulled its new drug application (NDA) for its drug, binimetinib, for the treatment …

News
shutterstock_311949818

Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures

March 20, 2017
Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche

Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …

News
china_wall

China proposes ways to speed up approval for imported drugs

March 20, 2017
Sales and Marketing China, imported drugs

It can currently take up to three or four years for a new drug to reach market in China, slowing …

News
pakistan-895319_960_720

Pakistan’s problem with diabetes – with 7 million diabetics

March 20, 2017
Medical Communications, Sales and Marketing Pakistan, Sanofi, diabetes

Pakistan is facing an increasing problem with people suffering from diabetes. At a recent conference, the 4th International Diabetes Conference, …

News
pulmocide-logo

UK biotech Pulmocide secures $30m for inhalable lung disease therapies

March 20, 2017
Research and Development, Sales and Marketing pulmocide, pulmonary aspergillosis, respiratory syncytial virus

Pulmocide, a UK biotech run by a former GlaxoSmithKline scientists and based in London, has secured $30.4 million in Series …

News
pregnant-1245703_960_720

Pregnancy test pill used through 60s & 70s connected with birth defects

March 20, 2017
Medical Communications, Sales and Marketing Bayer, Primodos

A pregnancy test, named Primodos, which was taken by 1.5 million British mothers and was linked to birth defects, may …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

As another week comes and goes, waves were sent through the industry as Trump announced his pick as the new …

News
boardroom

Enhancing scientific acumen in the pharma boardroom

March 17, 2017
Medical Communications R&D

Dana M. Krueger and Neha Rajdev, of Russell Reynolds, discuss the importance of a scientific background in the boardrooms of …

News
water-243910_960_720

FDA warns API manufacturer about river water as ingredient

March 17, 2017
Manufacturing and Production, Medical Communications Badrivishal Chemicals & Pharmaceuticals, FDA, India

The FDA has issued Badrivishal Chemicals & Pharmaceuticals a warning letter regarding numerous violations of manufacturing codes. The most worrying …

News
shutterstock_274590824

Ex-Novartis employee found not guilty of deceitful drug advertising

March 17, 2017
Medical Communications, Sales and Marketing Diovan, Novartis, legal

A Tokyo court has ruled finding ex-Novartis employee Nobuo Shirahashi and the company’s Tokyo-based sales arm Novartis Pharma KK not …

News
blood-1813410_960_720

AstraZeneca hit with second blow on $2.7 billion drug

March 17, 2017
Medical Communications AstraZeneca, FDA, hyperkalaemia

AstraZeneca paid $2.7 billion for ZS Pharma, back in 2015, with the desire to get its hands on the company’s …

News
anirvan_ghosh

Biogen swoops to appoint Ex-Roche Vice President

March 16, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen

Biogen have appointed Anirvan Ghosh to the position of Senior Vice President of research and Early Development. Ghosh is slated …

Appointment

NICE reverses decision on medication for relapsing multiple sclerosis

March 16, 2017
Sales and Marketing Biogen, zinbryta

The current topic of discussion regarding NICE is how its recent changes will impact patient access to medicine but, away …

News
7808465302_a335c6dd4f_o

The rising threat of antibiotic resistance

March 16, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance

Last month, researchers from the University of California, Los Angeles (UCLA) revealed findings that showed that utilising antibiotics in combination …

Feature
nice_reception_small_size

NICE drug expense limit of £20 million could cause treatment delays

March 16, 2017
Medical Communications, Sales and Marketing NHS England, NICE, fast-track appraisal process, rare disease

NICE has released its decision on the fast-track approval process and other changes that will be brought through at the …

News
china-pharmaceutical-industry

FDA warns China’s Lumis over misbranded APIs

March 16, 2017
Manufacturing and Production FDA, Lumis

Chinese firm Lumis Global Pharmaceuticals became the latest to face the FDA’s ire as it was hit by a warning …

News
pills-384846_960_720

US city takes drug company to court over opioid crisis

March 16, 2017
Medical Communications OxyContin, opioid, opioid crisis

The opioid crisis in North America continues to rumble on, ruining lives and causing untold damage to communities. One city, …

News
fdaoutsideweb

Trump’s proposed budget doubles FDA regulatory fees

March 16, 2017
Sales and Marketing FDA, Trump

Trump’s presidency could cost the industry more than twice as much in regulatory review fees next year, as his administration …

News
tablets

Ibuprofen linked to 31% increase in risk of cardiac arrest

March 16, 2017
Medical Communications cardiac arrest, ibuprofen

A study emerging from Denmark has found that the use of over-the-counter pain killer, Ibuprofen, is associated with an increased …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026